Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

alert: Assessment of LEscol in Renal Transplantation

principal CONTACTS

Bengt Fellstrom (Uppsala University, Sweden)

Hallvard Holdaas (Oslo University Hospital, Norway)

Terje Pedersen (University of Oslo, Norway)

data CUSTODIAN

Novartis Pharma AG

funding

Novartis Pharma AG

key publications